JapanStake
Information & Communication · Fiscal year end Mar 31

ADR Biomedical Holdings Inc.

3750

ＡＤＲバイオメディカルホールディングス株式会社

FIGI BBG000JMKG483750.T3750 JPCorp. no. 5011101038048

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-14

For the first half of the fiscal year to 2026-03: Revenue ¥0 billion (-80.0% YoY), Ordinary income ¥-0.3 billion, Net income ¥-0.1 billion.

This periodYear on year
Revenue¥18m-80.0%
Ordinary profit−¥348m—
Net profit to owners−¥131m—

From the securities report on EDINET, which states no forecast. History via /v1/companies/3750/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2026-03-31
Revenue
¥51m
Net income
−¥397m
ROE
-180.0%
Equity ratio
6.0%
Dividend / share
—
Employees
13
Revenue · ¥bn
FY2022: ¥1.3bn 1.34 FY2022FY2023: ¥2.1bn 2.14 FY2023FY2024: ¥1.6bn 1.56 FY2024FY2025: ¥0.1bn 0.12 FY2025FY2026: ¥0.1bn 0.05 FY2026
Net income · ¥bn
FY2022: −¥0.1bn -0.08 FY2022FY2023: −¥1.1bn -1.06 FY2023FY2024: ¥0.1bn 0.14 FY2024FY2025: −¥2.1bn -2.14 FY2025FY2026: −¥0.4bn -0.4 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥0.1bn−¥0.4bn¥0.4bn¥0.0bn-180.0%¥-44.46−¥0.8bn
2025-03-31¥0.1bn−¥2.1bn¥3.5bn¥0.6bn-142.8%¥-239.7−¥1.0bn
2024-03-31¥1.6bn¥0.1bn¥5.8bn¥2.8bn5.5%¥15.47−¥1.2bn
2023-03-31¥2.1bn−¥1.1bn¥14.1bn¥2.7bn-35.6%¥-118.71−¥0.0bn
2022-03-31¥1.3bn−¥0.1bn¥16.0bn¥3.7bn-2.3%¥-8.79−¥0.2bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %-1800.1
Ordinary margin-18.09620.2
Equity ratio, %62.9
Revenue growth-0.58280.4
Net income growth0.814582.4
Operating cash flow / assets-2.13220
Policy-uncertainty measure2.02 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Politics & geopolitics 2
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 0.0% held by other listed companies.

Results wording balance: 0.00. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/3750/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-06-26: see filing 上記の評価の結果、当事業年度末日時点において、当社の財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-06-26 · 定款一部変更の件 · passed. /v1/companies/3750/voting

Ownership changes

All companies →
  • 2026-05-08
    Increase+5.36pt

    TOKYO WELD CO.,LTD. raised holdings in ADR Biomedical Holdings Inc. (3750) to 14.58% from 9.22%.

    01020304050
    S100Y1Z6Filer profileOriginal filing (PDF, Japanese)
  • 2026-05-08
    Threshold

    Holdings of TOKYO WELD CO.,LTD. in ADR Biomedical Holdings Inc. (3750) moved above 10% (9.22% -> 14.58%).

    01020304050
    S100Y1Z6Filer profileOriginal filing (PDF, Japanese)
  • 2025-10-22
    New 5% stake

    FTL Capital Management K.K disclosed a 11.05% stake in ADR Biomedical Holdings Inc. (3750), crossing the 5% reporting threshold.

    01020304050
    S100WWAXFiler profileOriginal filing (PDF, Japanese)
  • 2025-10-22
    Threshold

    Holdings of FTL Capital Management K.K in ADR Biomedical Holdings Inc. (3750) moved above 10% (new -> 11.05%).

    01020304050
    S100WWAXFiler profileOriginal filing (PDF, Japanese)
  • 2025-07-15
    Below 5%−1.12pt

    individual filer cut holdings in ADR Biomedical Holdings Inc. (3750) to 4.40% from 5.52%, below the 5% threshold.

    01020304050
    S100WC77Original filing (PDF, Japanese)
  • 2025-04-09
    Stated it may make proposals+5.52pt

    individual filer states it may make proposals to the management of ADR Biomedical Holdings Inc. (3750) (first filing).

    01020304050
    S100VLC8Original filing (PDF, Japanese)
  • 2025-04-09
    New 5% stake+5.52pt

    individual filer disclosed a 5.52% stake in ADR Biomedical Holdings Inc. (3750), crossing the 5% reporting threshold.

    01020304050
    S100VLC8Original filing (PDF, Japanese)
  • 2025-03-06
    Increase+2.40pt

    individual filer raised holdings in ADR Biomedical Holdings Inc. (3750) to 18.50% from 16.10%.

    01020304050
    S100VCADOriginal filing (PDF, Japanese)
  • 2025-03-05
    Decrease−1.98pt

    individual filer reduced holdings in ADR Biomedical Holdings Inc. (3750) to 5.16% from 7.14%.

    01020304050
    S100VCK2Original filing (PDF, Japanese)
  • 2024-07-26
    Increase+1.79pt

    Catalyst Investment Group Co.,Ltd. raised holdings in ADR Biomedical Holdings Inc. (3750) to 10.67% from 8.88%.

    01020304050
    S100U42KFiler profileOriginal filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥878¥1,139¥1,400 2021-10-292025-02-28 2025-02-28 · sold 142,867 @ ¥926 · individual filer2025-02-28 · sold 12 @ ¥906 · individual filer2025-02-28 · bought 214,300 @ ¥926 · individual filer2025-01-20 · sold 110,000 @ ¥878 · individual filer2025-01-20 · bought 110,000 @ ¥878 · individual filer2024-07-25 · bought 159,600 @ ¥926 · カタリスト・インベストメント・グループ株式会社2024-05-24 · bought 293,300 @ ¥926 · カタリスト・インベストメント・グループ株式会社2024-05-24 · sold 169,133 @ ¥926 · individual filer2024-05-24 · sold 53,467 @ ¥926 · individual filer2024-03-21 · bought 253,500 @ ¥1,200 · カタリスト・インベストメント・グループ株式会社2024-03-21 · sold 253,500 @ ¥1,171 · 株式会社HGキャピタル2023-12-26 · sold 2,218,535 @ ¥1,068 · ACA株式会社2023-12-26 · bought 10,616 @ ¥1,068 · ACA株式会社2023-12-25 · sold 9,822 @ ¥1,080 · 株式会社HGキャピタル2023-12-21 · sold 57,245 @ ¥994 · 株式会社HGキャピタル2023-12-01 · sold 256,000 @ ¥1,090 · individual filer2023-12-01 · bought 256,000 @ ¥1,090 · individual filer2023-11-13 · sold 150,000 @ ¥1,123 · individual filer2023-11-13 · bought 150,000 @ ¥1,123 · individual filer2023-11-06 · sold 40,000 @ ¥1,134 · individual filer2023-11-06 · bought 40,000 @ ¥1,134 · individual filer2023-10-16 · sold 38,000 @ ¥1,155 · individual filer2023-10-16 · bought 38,000 @ ¥1,155 · individual filer2023-08-24 · sold 106,610 @ ¥938 · 株式会社HGキャピタル2023-06-07 · sold 256,000 @ ¥989 · individual filer2023-06-07 · bought 256,000 @ ¥989 · individual filer2023-05-19 · sold 50,000 @ ¥945 · individual filer2023-05-19 · bought 50,000 @ ¥945 · individual filer2023-05-18 · sold 100,000 @ ¥970 · individual filer2023-05-18 · bought 100,000 @ ¥970 · individual filer2023-05-17 · bought 124,216 @ ¥994 · individual filer2023-05-17 · sold 1,785,905 @ ¥994 · ACA株式会社2023-05-17 · sold 76,734 @ ¥994 · ACA株式会社2023-05-11 · sold 40,000 @ ¥1,020 · individual filer2023-05-11 · bought 40,000 @ ¥1,020 · individual filer2023-04-19 · sold 38,000 @ ¥1,191 · individual filer2023-04-19 · bought 38,000 @ ¥1,191 · individual filer2022-01-25 · bought 57,000 @ ¥1,022 · Nippon Opportunity Management LLC2021-12-27 · sold 143,000 @ ¥1,400 · ACA株式会社2021-12-20 · bought 40,000 @ ¥1,218 · Nippon Opportunity Management LLC2021-10-29 · sold 95,755 @ ¥926 · ACA株式会社
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
FTLキャピタルマネジメント株式会社2025-10-15 – 2025-10-15+986,406+11.05pt——
individual filer2025-03-19 – 2025-07-080+0.01pt——
individual filer2025-07-08 – 2025-07-08+351,300+3.93pt——
individual filer2023-04-19 – 2025-02-28+1,313,569+14.71pt¥1,026.06¥878–1,191
individual filer2023-05-17 – 2025-02-28-241,263−2.68pt¥943.25¥906–994
カタリスト・インベストメント・グループ株式会社2024-03-18 – 2024-07-25+952,906+10.67pt¥1,024.33¥926–1,200
株式会社HGキャピタル2023-05-17 – 2024-03-21+302,341+3.38pt¥1,087.04¥938–1,171
ACA株式会社2021-10-29 – 2024-03-18-4,555,819−51.05pt¥1,043.99¥926–1,400
株式会社東京ウエルズ2023-12-27 – 2023-12-2700.00pt——
Nippon Opportunity Management LLC2021-10-22 – 2022-03-03-1,204,300−13.48pt¥1,102.82¥1,022–1,218

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/3750/trades.

5% filings

Large shareholding reports on 3750
FiledFilerStakeChangeStated purpose
2026-05-08TOKYO WELD CO.,LTD.14.58%+5.36ptpure investment
2025-10-22FTL Capital Management K.K11.05%—collateral
2025-07-15individual filer4.40%−1.12ptmay make proposals pure investment
2025-04-09individual filer5.52%+5.52ptmay make proposals pure investment
2025-03-06individual filer18.50%+2.40ptpure investment
2025-03-05individual filer5.16%−1.98ptpure investment
2024-07-26Catalyst Investment Group Co.,Ltd.10.67%+1.79ptmanagement participation
2024-06-03Catalyst Investment Group Co.,Ltd.5.60%—management participation
2024-05-31individual filer10.23%−2.43ptpure investment
2024-05-31Catalyst Investment Group Co.,Ltd.8.88%+3.28ptmanagement participation

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
株式会社ＨＧキャピタル1,153,81412.92%
株式会社ＳＢＩ証券1,073,83412.03%
individual holder1,058,29511.85%
FTLキャピタルマネジメント株式会社986,40611.05%
株式会社東京ウエルズ823,1709.22%
日本証券金融株式会社594,0006.65%
individual holder460,8415.16%
individual holder376,2364.21%
individual holder113,8101.27%
individual holder102,4001.15%

Get this as JSON

GET /v1/companies/3750
GET /v1/companies/3750/financials
GET /v1/companies/3750/details
GET /v1/companies/3750/segments
GET /v1/companies/3750/voting
GET /v1/companies/3750/tender-offers
GET /v1/companies/3750/indicators
GET /v1/companies/3750/earnings-releases
GET /v1/events?ticker=3750
GET /v1/companies/3750/trades         
GET /v1/companies/3750/cross-holdings 
GET /v1/companies/3750/brief

Plans from $9 a month · Documentation